Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-29T16:25:17.588Z Has data issue: false hasContentIssue false
  • English
  • Français

Access to Medicines and the Transformation of the South African State: Exploring the Interactions of Legal and Policy Changes in Health, Intellectual Property, Trade, and Competition Law in the Context of South Africa's HIV/AIDS Pandemic

Published online by Cambridge University Press:  27 December 2018

Heinz Klug
Get access Rights & Permissions [Opens in a new window]

Abstract

Access to essential medicines remains highly contested around the globe and a vital issue in South Africa. At the same time, the HIV/AIDS pandemic and the demand for medical services are having important political and social consequences in a society heavily impacted by the pandemic. Legal and institutional changes within the postapartheid state in South Africa are in part a reflection of the interaction of opportunities and constraints both within and across the country's geographical boundaries. The transformation of state institutions in this context has been set in motion and shaped by different policy imperatives: from demands for medical care to the promotion of economic competition and the need to implement international trade commitments, including specific levels of intellectual property protection. Despite a strong commitment to social change, to address the legacies of apartheid, as well as the relative strength and political will of the dominant political party, the African National Congress, the transformation of a number of state institutions was significantly framed by the global environment in which the country found itself. In the context of South Africa's democratic transition and the devastating HIV/AIDS pandemic, the state responded to a range of shifting opportunities and constraints, whether real or perceived. As a result, impetus was given to different policies and competing political and economic factions, enabling particular institutions and rules to be embraced, created, reshaped, or simply foregone.

Type
Articles
Information
Law & Social Inquiry , Volume 37 , Issue 2 , Spring 2012 , pp. 297 - 329
Copyright
Copyright © American Bar Foundation, 2012 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

African National Congress (ANC). 1994a. A National Health Plan for South Africa: Prepared by the ANC with Technical Support of WHO and UNICEF. http://www.imsa.org.za/files/Library/NHI/Policy%20Brief%207/ANC%20HEALTH%20PLAN%201994.pdf (accessed September 3, 2011).Google Scholar
African National Congress (ANC). 1994b. The Reconstruction and Development Programme: A Policy Framework. Johannesburg: ANC.Google Scholar
African National Congress (ANC). 2009. National Health Insurance Policy Proposal, June 22, 2009. http://wikileaks.org/wiki/African_National_Congress_National_Health_Insurance_plan%2C_July_2009 (accessed September 29, 2011).Google Scholar
African National Congress (ANC). 2010. Additional Discussion Documents, Section 1: National Health Insurance. http://www.anc.org.za/docs/discus/2010/aditionalo.pdf (accessed September 3, 2011).Google Scholar
AIDS Law Project and Treatment Action Campaign. 2003. The Price of Life: Hazel Tau and Others versus GlaxoSmithKline and Boehringer Ingelheim. A Report on the Excessive Pricing Complaint to South Africa's Competition Commission. http://books.google.com/books?id=KLYk1B_9JRgC&pg=PA23&lpg=PA23&dq=Hazel+Tau&source=bl&ots=jEsbY4HFgl&sig=7beoN7cLkvdtKuChIy1V5xBQSXQ&hl=en&ei=cuKETqaLC4js0gGV9Jj6Dw&sa=X&oi=book_result&ct=result&resnum=9&ved=0CEwQ6AEwCA#v=onepage&q&f=false (accessed September 29, 2011).Google Scholar
Australian Federation of AIDS Organization. 2000. Letter of congratulations to Dr. Helen Rees, Chairperson of the MCC, dated December 12, 2000. http://www.iglhrc.org/cgi‐bin/iowa/article/pressroom/pressrelease/749.html (accessed September 3, 2011).Google Scholar
Berger, Jonathan. 2005. AIDS Law Project, letter to Angelo Kondes, CEO Abbot Labs, South Africa re shortages of Ritonavir, dated February 14, 2005. http://www.alp.org.za/modules.php?op=modload&name=Newsandfile=article&sid=237 (accessed on April 17, 2008).Google Scholar
Braithwaite, John, and Drahos, Peter. 2000. Global Business Regulation. Cambridge, UK: Cambridge University Press.Google Scholar
Business Insights. 2010. The South African Pharmaceutical Market Outlook to 2014: Policy Environment, Market Structure, Competitive Landscape, Growth Opportunities. http://www.articlesbase.com/health‐articles/south‐african‐pharmaceutical‐market‐outlook‐to‐2014‐policy‐environment‐market‐structure‐competitive‐landscape‐growth‐opportunities‐2871883.html (accessed September 29, 2011).Google Scholar
Consumer Project on Technology. 1999. Appendix B: Time‐Line of Disputes Over Compulsory Licensing and Parallel Importation in South Africa, August 5, 1999. http://www.cptech.org/ip/health/sa/sa‐timeline.txt (accessed September 3 2011.Google Scholar
Cox, Robert W. 1994. Global Restructuring: Making Sense of the Changing International Political Economy. In Global Restructuring in Political Economy and the Changing Global Order, ed. Stubbs, Richard and Underhill, Geoffrey R. D. New York: St. Martin's Press.Google Scholar
De Beer, Cedric. 1984. The South African Disease: Apartheid, Health and Health Services. Johannesburg: South African Research Service.Google Scholar
Deeb, M. T. 1998a. Founding Affidavit by M. T. Deeb, February 18, 1998, High Court of South Africa, Pretoria, South Africa.Google Scholar
Deeb, M. T. 1998b. Supplementary Affidavit by M. T. Deeb, July 23, 1998, High Court of South Africa. Pretoria, South Africa.Google Scholar
Department of Health. 1996. National Drug Policy for South Africa (January 1996). http://www.doh.gov.za/docs/policy/drugsjan1996.pdf (accessed September 29, 2011).Google Scholar
Department of Health. 1997. White Paper for the Transformation of the Health System in South Africa. Pretoria, South Africa: Government Press.Google Scholar
Drahos, Peter, and Braithwaite, John. 2002. Information Feudalism: Who Owns the Knowledge Economy? New York: The New Press.Google Scholar
Erwin, Alec. 1999. Interview. Global Dialogue, 4 (1).Google Scholar
Geffen, Nathan. 2010. Debunking Delusions: The Inside Story of the Treatment Action Campaign. Auckland Park, South Africa: Jacana Media.Google Scholar
Gevisser, Mark. 2007. Thabo Mbeki: A Dream Deferred. Cape Town, South Africa: Jonathan Ball.Google Scholar
Govender, Pregs. 2007. Love and Courage: A Story of Insubordination. Auckland Park, South Africa: Jacana Media.Google Scholar
Guehenno, Jean‐Marie. 1995. The End of the Nation‐State. Minneapolis: University of Minnesota Press.Google Scholar
Hansard. 1998. Debates of the National Assembly, Parliament, South Africa, vol. 19, September 9, 6835.Google Scholar
Harrison, David. 2009. An Overview of Health and Health Care in South Africa 1994—2010: Priorities, Progress and Prospects for New Gains (December 2009). http://www.doh.gov.za/docs/reports/2010/overview1994‐2010.pdf (accessed September 3, 2011).Google Scholar
Hassim, Adile, Heywood, Mark, and Berger, Jonathan, eds. 2007. Health & Democracy: A Guide to Human Rights, Health Law and Policy in Post‐Apartheid South Africa. Cape Town: SiberInk.Google Scholar
Held, David. 2004. Global Covenant: The Social Democratic Alternative to the Washington Consensus. Cambridge: Polity Press.Google Scholar
Held, David, McGrew, Anthony, Goldblatt, David, and Perraton, Jonathan. 1999. Global Transformations: Politics, Economics and Culture. Stanford, CA: Stanford University Press.Google Scholar
Heywood, Mark. 2005. The Achilles Heel? The Impact of HIV/AIDS on Democracy in South Africa. In HIV/AIDS in South Africa, ed. Abdool, S. Karin, S. and Karim, Q. Abdool. Cambridge: Cambridge University Press.Google Scholar
Hirsch, Alan. 2005. Season of Hope: Economic Reform under Mandela and Mbeki. Scottsville, South Africa: University of KwaZulu‐Natal.Google Scholar
Kapczynski, Amy. 2009. Harmonization and Its Discontents: A Case Study of TRIPS Implementation in India's Pharmaceutical Sector. California Law Review 97: 1571.Google Scholar
Kapczynski, Amy, and Berger, Jonathan. 2009. The Story of the TAC Case: The Potential and Limits of Socio‐Economic Rights Litigation in South Africa. In Human Rights Advocacy Stories, ed. Hurwitz, Deena R., Satterthwaite, Margaret L., and Ford, Douglas B. New York: Foundation Press.Google Scholar
Kaul, Inge, Conceicao, Pedro, le Goulven, Katell, and Mendoza, Ronald U. 2003. Why Do Global Public Goods Matter Today. In Providing Global Public Goods: Managing Globalization, ed. Kaul, Inge, Conceicao, Pedro, le Goulven, Katell, and Mendoza, Ronald U. Oxford: Oxford University Press/UNDP.Google Scholar
Kgara, Sidney and Barsel, Sheila. 2010. IPAP and the Need for a State‐owned Pharmaceutical Company. Special Issue: Towards a New Growth Path: African Communist no. 182:49–56.Google Scholar
Klug, Heinz. 2000. Constituting Democracy: Law, Globalism and South Africa's Political Reconstruction. Cambridge: Cambridge University Press.Google Scholar
Klug, Heinz. 2005. Campaigning for Life: Building a New Transnational Solidarity in the Face of HIV/AIDS and TRIPS. In Law and Globalization from Below: Towards a Cosmopolitan Legality, ed. de Sousa Santos, Boaventura and Rodreguez, Cesar A. Cambridge: Cambridge University Press.Google Scholar
Klug, Heinz. 2008. Law, Politics, and Access to Essential Medicines in Developing Countries. Politics and Society 36 (2): 207–45.Google Scholar
Klug, Heinz. 2010a. Risking Health: HIV/AIDS and the Problem of Access to Essential Medicines. In Disaster and the Politics of Intervention, ed. Lakoff, Andrew. New York: Columbia University Press and Social Science Research Council.Google Scholar
Klug, Heinz. 2010b. The Constitution of South Africa: A Contextual Analysis. Cambridge: Hart Publishing.Google Scholar
Kwamboka, Evelyn. 2011. High Court Enjoins UN in Case against Generic ARVs Ban. The Standard, January 17, 2011. http://www.standardmedia.co.ke/InsidePage.php?id=2000026980&cid=4 (accessed September 4, 2011).Google Scholar
Legh, Robert. 2002. A History of South African Competition Law. In Competition Law, ed. Brassey, Martin. Cape Town: Juta.Google Scholar
Mail and Guardian. 2008. Cartel Country. Mail and Guardian, June 13, 2008. http://mg.co.za/article/2008‐06‐13‐cartel‐country (accessed September 29, 2011).Google Scholar
Maloney, Christopher, and Myburgh, Andrew. 2007. Genesis: The Growth Potential of the Pharmaceuticals Sector in South Africa, May 29.Google Scholar
Marais, Hein. 2002. The Logic of Expediency: Post‐Apartheid Shifts in Macroeconomic Policy. In Thabo Mbeki's World: The Politics and Ideology of the South African President, ed. Jacobs, Sean and Calland, Richard. Scotsville, South Africa: University of Natal Press.Google Scholar
Medecins Sans Frontieres (MSF). 2007. Campaign for Access to Essential Medicines, Untangling the Web of Price Reductions: A Pricing Guide for the Purchase of ARVs for Developing Countries, 10th ed. http://www.accessmed‐msf.org (accessed September 4, 2011).Google Scholar
Medecins Sans Frontieres (MSF). 2011. Don't Swallow This Pill, January 20, 2011. http://www.msf.org/msf/articles/2011/01/dont‐swallow‐this‐pill.cfm (accessed September 4, 2011).Google Scholar
McIntyre, D., and Van den Heever, A. 2007. Social or National Health Insurance. In South African Health Review 2007, ed. Harrison, S., Bhana, R., and Ntuli, A. Durban, South Africa: Health Systems Trust. http://www.hst.org.za/uploads/files/chap5_07.pdf (accessed September 4, 2011).Google Scholar
McLeod, Heather. 2009. National Health Insurance Background Brief: NHI in South Africa: 1940–2008. Houghton, South Africa: Innovative Medicines South Africa. http://www.imsa.org.za/national_health_insurance_NHISA_1940_08_2.html (accessed September 4, 2011).Google Scholar
Mhone, Guy, and Edigheji, Omano, eds. 2003. Governance in the New South Africa: The Challenges of Globalization. Cape Town: University of Cape Town Press.Google Scholar
Moodaliyar, Kasturi, and Hartzenberg, Trudi. 2006. Report on the Fifth Annual Conference of the International Competition Network. http://www.internationalcompetitionnetwork.org (accessed September 4, 2011).Google Scholar
Mooney, Gavin H., and McIntyre, Diane E. 2008. South Africa: A 21st Century Apartheid in Health and Health Care? Medical Journal of Australia 189 (11/12): 637–40.Google Scholar
Nattrass, Nicoli. 2007. Mortal Combat: AIDS Denialism and the Struggle for Antiretrovirals in South Africa. Scottsville, South Africa: University of KwaZulu‐Natal Press.Google Scholar
O'Brien, Peter. 1998. The Normalization of the International Market for Pharmaceuticals: Future Impacts in Emerging Markets. In Medicines and the New Economic Environment, ed. Lobo, Felix and Velasquez, German. Madrid: WHO, University Carlos III, Civitas.Google Scholar
Ohmae, Kenichi. 1990. The Borderless World: Power and Strategy in the Inter‐linked Economy. New York: Harper Business.Google Scholar
Ottaway, Marina. 1993. South Africa: The Struggle for a New Order. Washington, DC: Brookings Institution Press.Google Scholar
Petryna, Adriana, and Kleinman, Arthur. 2006. The Pharmaceutical Nexus. In Global Pharmaceuticals: Ethics, Markets, Practices, ed. Petryna, Adriana, Lakoff, Andrew, and Kleinman, Arthur. Durham, NC: Duke University Press.Google Scholar
Pile, Jacqui. 2005. Aspen Pharamcare: Clinical Coup. Financial Mail, July 15, 2005.Google Scholar
Rogowski, Ronald. 1989. Commerce and Coalitions: How Trade Affects Domestic Political Alignments. Princeton, NJ: Princeton University Press.Google Scholar
Ruggie, John Gerard. 2003. Taking Embedded Liberalism Global: the Corporate Connection. In Taming Globalization: Frontiers of Governance, ed. Held, David and Koenig‐Archibugi, Mathias. Cambridge: Polity Press.Google Scholar
Sachs, Albie. 2009. The Strange Alchemy of Life and Law. Oxford: Oxford University Press.Google Scholar
Sanders, David, and Chopra, Mickey. 2006. Key Challenges to Achieving Health for All in an Inequitable Society: The Case of South Africa. American Journal of Public Health 96 (1): 73–78.Google Scholar
Santos, Boaventura De Sousa and Rodreguez, Cesar A, eds. 2005. Law and Globalization from Below: Towards a Cosmopolitan Legality. Cambridge: Cambridge University Press.Google Scholar
Saul, John S. 2002. Cry for the Beloved Country: The Post‐Apartheid Denouement. In Thabo Mbeki's World: The Politics and Ideology of the South African President, ed. Jacobs, Sean and Calland, Richard. Scotsville, South Africa: University of Natal Press.Google Scholar
Section27 and TAC. 2010. Section27 and TAC Applaud Successful ARV Medicine Tender—But Call for Continued Actions to Drive Price of Essential Medicines Down Further, December 15. http://www.section27.org.za/wp‐content/uploads/2010/12/ARV_2010_Tender.pdf (accessed September 4, 2011).Google Scholar
Sell, Susan. 2003. Private Power, Public Law: The Globalization of Intellectual Property Rights. Cambridge: Cambridge University Press.Google Scholar
Shaffer, Gregory. 2011. Transnational Legal Process and State Change. Law & Social Inquiry DOI: 10.1111/j.1747‐4469.2011.01265.x.Google Scholar
Shaden, Kenneth. 2007. The Political Economy of AIDS Treatment: Intellectual Property and the Transformation of Generic Supply. International Studies Quarterly, 51 (3): 559–81.Google Scholar
Stokes, Bruce. 2005. Pachyderm Pharma. National Journal, April 16, 2005.Google Scholar
t'Hoen, Ellen. 2009. The Global Politics of Pharmaceutical Monopoly Power: Drug Patents, Access, Innovation and the Application of the WTO DOHA Declaration on TRIPS and Public Health. Diemen, the Netherlands: AMB Publishers.Google Scholar
Thom, Anso. 2010. Change at the MCC—Too Little, Too Late? http://www.health‐e.org.za/news/article.php?uid=20032808 (accessed September 29, 2011).Google Scholar
van Rensburg, H. C. J. 2004. HCI, National Health Systems: Structure, Types and Dynamics. In Health and Health Care in South Africa, ed. van Rensburg, H. C. J. Pretoria, South Africa: Van Schaik.Google Scholar
van Rensburg, H. C. J. and Pelser, A.J. 2004. The Transformation of the South African Health System. In Health and Health Care in South Africa. ed. van Rensburg, H. C. J., Pretoria: Van Schaik.Google Scholar
World Health Organization (WHO). 2003. News Release, World Health Organization Says Failure to Deliver AIDS Medicines Is a Global Health Emergency: Global AIDS Treatment Emergency Requires Urgent Response—No More Business as Usual. http://www.who.int/mediacentre/releases/2003/pr67/en/print.html (site no longer active).Google Scholar
Woodward, David, and Smith, Richard D. 2003. Global Public Goods and Health: Concepts and Issues. In Global Public Goods For Health: Health Economic and Public Health Perspectives, ed. Smith, Richard, Beaglehole, Robert, Woodward, David, and Drager, Nick. Oxford: Oxford University Press.Google Scholar

Cases Cited

National Association of Pharmaceutical Wholesalers & Others v Glaxo Wellcome (Proprietary) Ltd & Others, (68/IR/Jun00) [2000] ZACT 15 (April 28, 2000).Google Scholar
Commission for Conciliation, Mediation and Arbitration Award in the case of Public Servants Association of South Africa (on behalf of J. Schlebusch & C. Brückner) vs. the Department of Health, Case No. GA51345, Commissioner J. Hiemstra, awarded on November 26, 1999.Google Scholar
Glaxo Wellcome plc v Smithkline Beecham plc, (58/AM/May00) [2000] ZACT 33 (July 28, 2000).Google Scholar
Hazel Tau v GlaxoSmithKline and Boehringer, (complaint brought before the Competition Commission, but case was settled out of court, 2002).Google Scholar

South Africa

Government Notice 180, Government Gazette No. 33006, March 12, 2010.Google Scholar
Government Notice 801, Government Gazette No. 10211, May 2, 1986.Google Scholar
Government Notice 903, Government Gazette No. 32564, September 11, 2009.Google Scholar
Medicines Act 101 of 1965, June 19, 1965, as amended by the Medicines and Related Substances Amendment Act 59 of 2002, January 17, 2003. http://www.mccza.com/dynamism/default_dynamic.asp?grpID=26&doc=dynamic_generated_page.asp&categID=142&groupID=26.Google Scholar
Medicines and Related Substances Control Amendment Act 90 of 1997, December 12, 1997, Government Gazette No. 18505.Google Scholar

United Nations

Revised Drug Strategy, World Health Assembly Resolution WHA 52.19, May 24, 1999, available at http://keionline.org/sites/default/files/WHA52.19_e19_revised_drug_strategy.pdf.Google Scholar

United States

Public Law No. 105‐277, October 21, 1998, 112 Stat. 2681‐155, available at http://www.gpo.gov/fdsys/pkg/PLAW‐105publ277/pdf/PLAW‐105publ277.pdf.Google Scholar

World Trade Organization

Council for TRIPS, “Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health,” IP/C/W/405, August 30, 2003, and accompanying chairman's statement. http://www.wto.org/english/news_e/pres03_e/pr350_e.htm.Google Scholar
Declaration on the TRIPS Agreement and Public Health, adopted at the DOHA WTO Ministerial Meeting, November 14, 2001, sec. 6. http://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_trips_e.htm.Google Scholar